Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs NINTEDANIB ESYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs NINTEDANIB ESYLATE: Safety Overview

Metric NILOTINIB NINTEDANIB ESYLATE
Total FAERS Reports 23,171 117
Deaths Reported 4,543 23
Death Rate 19.6% 19.7%
Hospitalizations 4,846 39
Average Patient Age 56.5 yrs 66.4 yrs
% Female Patients 47.7% 47.8%
FDA Approval Date Dec 15, 2025 Oct 15, 2014
Manufacturer Novadoz Pharmaceuticals LLC Boehringer Ingelheim Pharmaceuticals,...
Route ORAL ORAL
Marketing Status Prescription Prescription